Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Intercept Pharmaceuticals (ICPT)

Intercept Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ICPT
DateTimeSourceHeadlineSymbolCompany
09/05/202413:00GlobeNewswire Inc.Intercept Announces New PBC Data Analyses to be Presented at Digestive Disease Week® 2024 ConferenceNASDAQ:ICPTIntercept Pharmaceuticals Inc
29/02/202413:30GlobeNewswire Inc.Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBCNASDAQ:ICPTIntercept Pharmaceuticals Inc
20/11/202317:09Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:ICPTIntercept Pharmaceuticals Inc
15/11/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ICPTIntercept Pharmaceuticals Inc
15/11/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202319:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202319:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202319:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202319:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202319:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202319:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202319:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202319:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202319:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202319:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202319:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202319:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202319:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202319:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202319:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202313:00GlobeNewswire Inc.Intercept Announces New Phase 2 Data Showing Significant Impact of OCA-Bezafibrate Combination on Normalization of Multiple Key Biomarkers of PBC-Induced Liver Damage at AASLD The Liver Meeting® 2023NASDAQ:ICPTIntercept Pharmaceuticals Inc
10/11/202313:00GlobeNewswire Inc.Intercept Announces New Findings from Long-term Extension of Landmark POISE Trial in PBC Showing Importance of Biomarkers Beyond ALP at AASLD The Liver Meeting® 2023NASDAQ:ICPTIntercept Pharmaceuticals Inc
08/11/202321:44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICPTIntercept Pharmaceuticals Inc
08/11/202321:28Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ICPTIntercept Pharmaceuticals Inc
08/11/202321:28Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ICPTIntercept Pharmaceuticals Inc
08/11/202321:26Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ICPTIntercept Pharmaceuticals Inc
08/11/202321:21Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ICPTIntercept Pharmaceuticals Inc
08/11/202321:21Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ICPTIntercept Pharmaceuticals Inc
08/11/202321:20Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ICPTIntercept Pharmaceuticals Inc
08/11/202321:19Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ICPTIntercept Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ICPT